Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
JCV serology in time: 3 years of follow-up.
Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis.
Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.
Estrogen receptors and esterol-dependent neuroprotective actions: a pilot study.
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
Ontogeny of Tissue-Resident Macrophages.
Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia.
Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats.
Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Acute inflammatory demyelinating polyradiculoneuropathy in a newborn infant.
The Dress: Transforming a web viral event into a scientific survey.
The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro.
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Three cases of neuromyelitis optica spectrum disorder.
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).
Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Pages
« first
‹ previous
…
836
837
838
839
840
841
842
843
844
…
next ›
last »